Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.hpb.2016.10.006
DC FieldValue
dc.titleSame admission laparoscopic cholecystectomy for acute cholecystitis: is the "golden 72 hours" rule still relevant?
dc.contributor.authorTan J.K.H.
dc.contributor.authorGoh J.C.I.
dc.contributor.authorLim J.W.L.
dc.contributor.authorShridhar I.G.
dc.contributor.authorMadhavan K.
dc.contributor.authorKow A.W.C.
dc.date.accessioned2018-08-29T08:58:39Z
dc.date.available2018-08-29T08:58:39Z
dc.date.issued2017-01-01
dc.identifier.citationTan J.K.H., Goh J.C.I., Lim J.W.L., Shridhar I.G., Madhavan K., Kow A.W.C. (2017-01-01). Same admission laparoscopic cholecystectomy for acute cholecystitis: is the "golden 72 hours" rule still relevant?. HPB 19 (1) : 47-51. ScholarBank@NUS Repository. https://doi.org/10.1016/j.hpb.2016.10.006
dc.identifier.issn1365182X
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/146722
dc.description.abstractBackground Studies have shown that same admission laparoscopic cholecystectomy (SALC) is superior to delayed laparoscopic cholecystectomy for acute cholecystitis (AC). While some proposed a“golden 72-hour” for SALC, the optimal timing remains controversial. The aim of the study was to compare the outcomes of SALC in AC patients with different time intervals from symptom onset. Methods A retrospective analysis of 311 patients who underwent SALC for AC from June 2010–June 2015 was performed. Patients were divided into three groups based on the time interval between symptom onset and surgery: <4 days (E-SALC), 4–7 days (M-SALC), >7 (L-SALC). Results The mean duration of symptoms was 2(1–3), 5(4–7) and 9 (8–13) days for E-SALC, M-SALC and L-SALC, respectively (p < 0.001). Conversion rates were higher in the L-SALC group [E-SALC, 8.2% vs M-SALC, 9.6% vs L-SALC, 21.4%] (p = 0.048). The total length of stay was longer in patients with longer symptom duration [E-SALC, 4 (2–33) vs M-SALC, 2 (2–23) vs L-SALC, 7 (2–49)] (p < 0.001). Conclusion Patients with AC presenting beyond 7 days of symptoms have higher conversion rates and longer length of stay associated with SALC. However, patients with less than a week of symptoms should be offered SALC. © 2016 International Hepato-Pancreato-Biliary Association Inc.
dc.publisherElsevier B.V.
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentSURGERY
dc.description.doi10.1016/j.hpb.2016.10.006
dc.description.sourcetitleHPB
dc.description.volume19
dc.description.issue1
dc.description.page47-51
dc.description.codenHPBIF
dc.published.statepublished
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.